| Followers | 21 |
| Posts | 2227 |
| Boards Moderated | 0 |
| Alias Born | 06/08/2009 |
Thursday, February 10, 2011 4:34:45 AM
As long as they get near enough to their estimate that's fine - within a million or 2. It's not like were priced for perfection.
Then the auditor and the cash flow remains strong (maybe Q1 may be better for cash after Q4's ramp-up?). And they use their cash wisely - show they are not another Chinese firm that just dilutes.
Approval of Zushima is probably out of their hands?
I think it's all going to be sector driven - but this could be more transparent than most. Should explain what happened to that herb project. Now, can we get them to be as shareholder friendly as CCME!
rich
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
